Target intelligence / Profile preview

Dactylis glomerata pollen allergens

Molecular classification
Allergen
01

Overview

Dactylis glomerata pollen allergens are extracts from the pollen of the orchard grass (Dactylis glomerata) plant, primarily used in diagnostic testing and immunotherapy for grass pollen allergies. These allergens, including specific proteins like Dac g 3 and Dac g 4, trigger IgE-mediated immune responses leading to allergic rhinitis with or without conjunctivitis in sensitized individuals. They are key components in products like Oralair and standardized grass pollen extracts, approved for sublingual or injection use in patients aged 5-65 with confirmed sensitivity via skin tests or IgE assays. Poaceae family pollen allergens like these are classified by protein structure and function, contributing to seasonal allergies from atmospheric exposure. While not traditional therapeutic targets like receptors or enzymes, they serve as antigens in allergen-specific immunotherapy to induce tolerance and reduce symptoms. Safety concerns include heightened hypersensitivity risks when combined with certain drugs like beta-blockers.

Other names
Dactylis glomerata pollenorchard grass pollen extractcocksfoot grass pollenstandardized orchard grass pollenallergenic extract- orchard grass dactylis glomerata
02

Biological functions

Allergic reactionBinds to IgECauses grass pollen allergy
03

Disease associations

Allergic rhinitis due to pollenGrass pollen allergy
04

Safety considerations

Hypersensitivity reaction risk (increased with beta-blockers like acebutolol, alprenolol, atenolol)Adverse effects in allergic rhinitis treatmentContraindications and blackbox warnings apply
05

Interacting drugs

Oralair (contains Dactylis glomerata pollen extract)

6 more in the full profile.

06

Biomarkers

Positive skin testIn vitro testing for pollen-specific IgE antibodies

Beyond the preview

Go deeper on Dactylis glomerata pollen allergens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dactylis glomerata pollen allergens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call